İsmail Savaş

655 total citations
35 papers, 314 citations indexed

About

İsmail Savaş is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, İsmail Savaş has authored 35 papers receiving a total of 314 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 10 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in İsmail Savaş's work include Lung Cancer Treatments and Mutations (6 papers), Lung Cancer Diagnosis and Treatment (5 papers) and Venous Thromboembolism Diagnosis and Management (4 papers). İsmail Savaş is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Lung Cancer Diagnosis and Treatment (5 papers) and Venous Thromboembolism Diagnosis and Management (4 papers). İsmail Savaş collaborates with scholars based in Türkiye, United States and Italy. İsmail Savaş's co-authors include Akın Kaya, Aydın Çiledağ, Banu Eriş Gülbay, Elif Şen, Gökhan Çelik, Ö Özdemir, Hülya Nilgün Gürses, Nalan Demir, Serhat Erol and Zeliha Kayaaltı and has published in prestigious journals such as Journal of Thoracic and Cardiovascular Surgery, Clinica Chimica Acta and Occupational and Environmental Medicine.

In The Last Decade

İsmail Savaş

34 papers receiving 299 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
İsmail Savaş Türkiye 8 95 93 64 54 53 35 314
Yasutomo Suzuki Japan 11 105 1.1× 118 1.3× 22 0.3× 82 1.5× 58 1.1× 56 382
Ming Su China 11 89 0.9× 52 0.6× 20 0.3× 31 0.6× 70 1.3× 28 300
Erna Busch United States 10 126 1.3× 38 0.4× 93 1.5× 133 2.5× 187 3.5× 11 501
Yan‐Ping Zhu China 9 85 0.9× 49 0.5× 14 0.2× 44 0.8× 95 1.8× 25 259
Yibo Wang China 11 77 0.8× 59 0.6× 12 0.2× 57 1.1× 145 2.7× 18 340
Fengfeng Xu China 9 63 0.7× 138 1.5× 10 0.2× 36 0.7× 26 0.5× 11 416
Emma E. McGee United States 9 67 0.7× 30 0.3× 15 0.2× 15 0.3× 50 0.9× 15 214
Shangqian Wang China 13 95 1.0× 157 1.7× 34 0.5× 45 0.8× 58 1.1× 19 431
E.J. Nouwen Belgium 12 41 0.4× 92 1.0× 21 0.3× 8 0.1× 42 0.8× 20 333

Countries citing papers authored by İsmail Savaş

Since Specialization
Citations

This map shows the geographic impact of İsmail Savaş's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by İsmail Savaş with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites İsmail Savaş more than expected).

Fields of papers citing papers by İsmail Savaş

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by İsmail Savaş. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by İsmail Savaş. The network helps show where İsmail Savaş may publish in the future.

Co-authorship network of co-authors of İsmail Savaş

This figure shows the co-authorship network connecting the top 25 collaborators of İsmail Savaş. A scholar is included among the top collaborators of İsmail Savaş based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with İsmail Savaş. İsmail Savaş is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Coşkun, Abdurrahman, et al.. (2025). From population-based to personalized laboratory medicine: continuous monitoring of individual laboratory data with wearable biosensors. Critical Reviews in Clinical Laboratory Sciences. 62(3). 198–227. 8 indexed citations
2.
Savaş, İsmail, et al.. (2024). A comparative analysis of serum NSE, LDH and CEA levels in lung cancer and extrapulmonary malignancies. Clinica Chimica Acta. 558. 119582–119582. 1 indexed citations
3.
Erol, Serhat, Aydın Çiledağ, Koray Ceyhan, et al.. (2024). Importance of mediastinal granulomatous/sarcoid‐like lymphadenopathy in extrathoracic malignancies. Diagnostic Cytopathology. 52(9). 475–479.
4.
Erol, Serhat, et al.. (2021). Using RV/LV ratio and cardiac biomarkers to define the risk of mortality from pulmonary embolism. Tuberkuloz ve Toraks. 69(3). 297–306. 5 indexed citations
5.
Çiledağ, Aydın, Serhat Erol, Elif Şen, et al.. (2021). Is endobronchial ultrasound-transbronchial needle aspiration (EBUS-TBNA) reliable and safe procedure in geriatric patients?. Aging Clinical and Experimental Research. 34(4). 913–925. 2 indexed citations
6.
Savaş, İsmail, et al.. (2018). Frequency of vitamin K oxidoreductase complex subunit-1 (VKORC1) polymorphisms and warfarin dose management in patients with venous thromboembolism. The Pharmacogenomics Journal. 18(5). 646–651. 1 indexed citations
7.
Çiledağ, Aydın, Gökhan Çelik, Nalan Demir, et al.. (2018). High serum YKL-40 level is associated with poor prognosis in patients with lung cancer. Tuberkuloz ve Toraks. 66(4). 273–279. 5 indexed citations
8.
Kaya, Akın, et al.. (2016). Septic Pulmonary Embolism: three Case Reports. Monaldi Archives for Chest Disease. 69(2). 75–7. 1 indexed citations
9.
Çiledağ, Aydın, Nalan Demir, Gökhan Çelik, et al.. (2015). Prognostic significance of serum vascular endothelial growth factor and Angiopoietin-2 in patients with lung cancer. Tuberkuloz ve Toraks. 63(2). 71–77. 7 indexed citations
10.
Çiledağ, Aydın, Elif Şen, Koray Ceyhan, et al.. (2015). The underlying causes of granulomatous lymphadenitis detected by EBUS-TBNA. PA788–PA788. 2 indexed citations
11.
Demir, Nalan, Serkan Enön, Zeliha Kayaaltı, et al.. (2014). Association of Cadmium but not Arsenic Levels in Lung Cancer Tumor Tissue with Smoking, Histopathological Type and Stage. Asian Pacific Journal of Cancer Prevention. 15(7). 2965–2970. 12 indexed citations
12.
Kaya, Akın, et al.. (2005). Vascular Endothelial Growth Factor in Benign and Malignant Pleural Effusions. Archivos de Bronconeumología. 41(7). 376–379. 10 indexed citations
13.
Kaya, Akın, Aydın Çiledağ, Banu Eriş Gülbay, et al.. (2004). The prognostic significance of vascular endothelial growth factor levels in sera of non-small cell lung cancer patients. Respiratory Medicine. 98(7). 632–636. 81 indexed citations
14.
Savaş, İsmail, et al.. (2004). Immunoglobulins and complement components in patients with lung cancer.. PubMed. 52(1). 19–23. 21 indexed citations
15.
Savaş, İsmail, et al.. (2003). [A patient with meningeal carcinomatosis and small cell lung cancer].. PubMed. 51(3). 303–5. 1 indexed citations
16.
Idılman, Ramazan, Hülya Çetınkaya, İsmail Savaş, et al.. (2001). Bronchoalveolar lavage fluid analysis in individuals with chronic hepatitis C. Journal of Medical Virology. 66(1). 34–39. 36 indexed citations
17.
Atalay, Figen, et al.. (2000). Sister chromatid exchange rate from pleural fluid cells in patients with malignant mesothelioma. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 465(1-2). 159–163. 8 indexed citations
18.
Savaş, İsmail, et al.. (2000). Urine deoxypyridinoline level: an alternative to bone scan in lung cancer?. Clinical Biochemistry. 33(7). 591–593. 1 indexed citations
19.
Savaş, İsmail, et al.. (2000). Urine deoxypyridinoline level…An alternative to bone scan in lung cancer?. Lung Cancer. 29(1). 257–257. 1 indexed citations
20.
Güngör, Âdem, et al.. (1996). Huge thymic cysts. Journal of Thoracic and Cardiovascular Surgery. 112(3). 835–836. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026